Published in Biochim Biophys Acta on July 24, 2007
Role of Marine Natural Products in the Genesis of Antiviral Agents. Chem Rev (2015) 0.82
An entry to curcuphenol/elvirol core structures via a retro-Aldol reaction. Chem Biodivers (2011) 0.75
Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrob Agents Chemother (1997) 9.16
Selective inhibition of human immunodeficiency viruses by racemates and enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine. Antimicrob Agents Chemother (1992) 3.52
Marine natural products as novel antioxidant prototypes. J Nat Prod (2003) 1.70
Three new manzamine alkaloids from a common Indonesian sponge and their activity against infectious and tropical parasitic diseases. J Nat Prod (2004) 1.36
Microbial and chemical transformation studies of the bioactive marine sesquiterpenes (S)-(+)-curcuphenol and -curcudiol isolated from a deep reef collection of the Jamaican sponge Didiscus oxeata. J Nat Prod (2002) 1.22
Abrogation of cisplatin-induced hepatotoxicity in mice by xanthorrhizol is related to its effect on the regulation of gene transcription. Toxicol Appl Pharmacol (2004) 0.97
(+)-Curcuphenol and dehydrocurcuphenol, novel sesquiterpenes which inhibit H,K-ATPase, from a marine sponge Epipolasis sp. Experientia (1987) 0.95
Lipoxygenase-catalyzed polymerization of phenolic lipids suggests a new mechanism for allergic contact dermatitis induced by urushiol and its analogs. Biochem Biophys Res Commun (2004) 0.91
Anti-AIDS agents. 46. Anti-HIV activity of harman, an anti-HIV principle from Symplocos setchuensis, and its derivatives. J Nat Prod (2001) 0.84
[Antimycobacterial indole derivatives]. Arch Pharm (Weinheim) (1994) 0.81
Total synthesis of (S)-(+)-curcudiol, and (S)-(+)- and (R)-(-)-curcuphenol. Chem Pharm Bull (Tokyo) (2001) 0.80
Novel sparteine-mediated enantio-dichotomic formal synthesis of R-(-)- and S-(+)-curcuphenol. J Org Chem (2001) 0.80
Synthesis and antimycobacterial activity of some indole derivatives of pyridine-2-carboxamidrazone and quinoline-2-carboxamidrazone. Farmaco (1996) 0.80
Marine natural products and their potential applications as anti-infective agents. Lancet Infect Dis (2003) 2.02
Marine indole alkaloids: potential new drug leads for the control of depression and anxiety. Chem Rev (2010) 1.83
New manzamine alkaloids with activity against infectious and tropical parasitic diseases from an Indonesian sponge. J Nat Prod (2003) 1.81
Lamellarins and related pyrrole-derived alkaloids from marine organisms. Chem Rev (2007) 1.78
Marine natural products as novel antioxidant prototypes. J Nat Prod (2003) 1.70
Indole alkaloid marine natural products: an established source of cancer drug leads with considerable promise for the control of parasitic, neurological and other diseases. Life Sci (2005) 1.64
The manzamine alkaloids. Alkaloids Chem Biol (2003) 1.46
New antiinfective and human 5-HT2 receptor binding natural and semisynthetic compounds from the Jamaican sponge Smenospongia aurea. J Nat Prod (2002) 1.45
Three new manzamine alkaloids from a common Indonesian sponge and their activity against infectious and tropical parasitic diseases. J Nat Prod (2004) 1.36
Marine pharmacology in 2001--2002: marine compounds with anthelmintic, antibacterial, anticoagulant, antidiabetic, antifungal, anti-inflammatory, antimalarial, antiplatelet, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems and other miscellaneous mechanisms of action. Comp Biochem Physiol C Toxicol Pharmacol (2005) 1.34
The expanding role of marine microbes in pharmaceutical development. Curr Opin Biotechnol (2010) 1.30
Marine pharmacology in 2003-4: marine compounds with anthelmintic antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiplatelet, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of action. Comp Biochem Physiol C Toxicol Pharmacol (2007) 1.30
Structure and absolute configuration of karlotoxin-2, an ichthyotoxin from the marine dinoflagellate Karlodinium veneficum. J Am Chem Soc (2010) 1.29
Cyanthiwigin AC and AD, two novel diterpene skeletons from the Jamaican sponge Myrmekioderma styx. Org Lett (2003) 1.28
Manadomanzamines A and B: a novel alkaloid ring system with potent activity against mycobacteria and HIV-1. J Am Chem Soc (2003) 1.27
Manzamine B and E and ircinal A related alkaloids from an Indonesian Acanthostrongylophora sponge and their activity against infectious, tropical parasitic, and Alzheimer's diseases. J Nat Prod (2006) 1.25
Marine pharmacology in 2000: marine compounds with antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiplatelet, antituberculosis, and antiviral activities; affecting the cardiovascular, immune, and nervous systems and other miscellaneous mechanisms of action. Mar Biotechnol (NY) (2003) 1.24
Microbial and chemical transformation studies of the bioactive marine sesquiterpenes (S)-(+)-curcuphenol and -curcudiol isolated from a deep reef collection of the Jamaican sponge Didiscus oxeata. J Nat Prod (2002) 1.22
Cyclic heptapeptides from the Jamaican sponge Stylissa caribica. J Nat Prod (2006) 1.20
Potent taccalonolides, AF and AJ, inform significant structure-activity relationships and tubulin as the binding site of these microtubule stabilizers. J Am Chem Soc (2011) 1.20
Toward computing relative configurations: 16-epi-latrunculin B, a new stereoisomer of the actin polymerization inhibitor latrunculin B. J Am Chem Soc (2002) 1.10
Glycogen synthase kinase-3 (GSK-3) inhibitory activity and structure-activity relationship (SAR) studies of the manzamine alkaloids. Potential for Alzheimer's disease. J Nat Prod (2007) 1.05
Latrunculin with a highly oxidized thiazolidinone ring: structure assignment and actin docking. Org Lett (2007) 1.05
Microbial metabolism studies of cyanthiwigin B and synergetic antibiotic effects. J Nat Prod (2006) 1.04
Lysosome and HER3 (ErbB3) selective anticancer agent kahalalide F: semisynthetic modifications and antifungal lead-exploration studies. J Med Chem (2007) 1.02
Marine natural products as prototype agrochemical agents. J Agric Food Chem (2003) 1.02
Secondary metabolites from three Florida sponges with antidepressant activity. J Nat Prod (2008) 1.02
The Mediterranean red alga Asparagopsis: a source of compounds against Leishmania. Mar Drugs (2009) 1.01
Marine pharmacology in 1999: compounds with antibacterial, anticoagulant, antifungal, anthelmintic, anti-inflammatory, antiplatelet, antiprotozoal and antiviral activities affecting the cardiovascular, endocrine, immune and nervous systems, and other miscellaneous mechanisms of action. Comp Biochem Physiol C Toxicol Pharmacol (2002) 0.99
Anti-infective discorhabdins from a deep-water alaskan sponge of the genus Latrunculia. J Nat Prod (2010) 0.95
Mollamides B and C, Cyclic hexapeptides from the indonesian tunicate Didemnum molle. J Nat Prod (2008) 0.95
Monitoring bacterial diversity of the marine sponge Ircinia strobilina upon transfer into aquaculture. Appl Environ Microbiol (2008) 0.94
Methicillin-resistant Staphylococcus aureus (MRSA)-active metabolites from Platanus occidentalis (American Sycamore). J Nat Prod (2009) 0.94
The marine bromotyrosine derivatives. Alkaloids Chem Biol (2005) 0.93
Modification at the C9 position of the marine natural product isoaaptamine and the impact on HIV-1, mycobacterial, and tumor cell activity. Bioorg Med Chem (2006) 0.93
Structural activity relationship studies of zebra mussel antifouling and antimicrobial agents from verongid sponges. J Nat Prod (2004) 0.91
Characterization of the bacterial community of the chemically defended Hawaiian sacoglossan Elysia rufescens. Appl Environ Microbiol (2013) 0.90
Identification of antidepressant drug leads through the evaluation of marine natural products with neuropsychiatric pharmacophores. Pharmacol Biochem Behav (2007) 0.90
Biological and molecular docking studies on coagulin-H: Human IL-2 novel natural inhibitor. Mol Immunol (2006) 0.89
Biocatalytic and semisynthetic optimization of the anti-invasive tobacco (1S,2E,4R,6R,7E,11E)-2,7,11-cembratriene-4,6-diol. Bioorg Med Chem (2008) 0.88
Structure-activity relationship and mechanism of action studies of manzamine analogues for the control of neuroinflammation and cerebral infections. J Med Chem (2010) 0.88
Antimalarial activity of a new family of analogues of manzamine A. Org Lett (2006) 0.88
Polyether ionophores: broad-spectrum and promising biologically active molecules for the control of drug-resistant bacteria and parasites. Expert Opin Drug Discov (2009) 0.87
Kinetic studies and bioactivity of potential manzamine prodrugs. J Nat Prod (2008) 0.87
5-OHKF and NorKA, depsipeptides from a Hawaiian collection of Bryopsis pennata: binding properties for NorKA to the human neuropeptide Y Y1 receptor. J Nat Prod (2009) 0.86
Hydrolysis reactions of the taccalonolides reveal structure-activity relationships. J Nat Prod (2013) 0.86
Synthesis and biological evaluation of manzamine analogues. Org Lett (2006) 0.86
Chemistry and biology of kahalalides. Chem Rev (2011) 0.85
Source, concentration, and distribution of elemental mercury in the atmosphere in Toronto, Canada. Environ Pollut (2011) 0.84
Chemically diverse microtubule stabilizing agents initiate distinct mitotic defects and dysregulated expression of key mitotic kinases. Biochem Pharmacol (2013) 0.84
Significance of endangered and threatened plant natural products in the control of human disease. Proc Natl Acad Sci U S A (2013) 0.84
Antiviral and anticancer optimization studies of the DNA-binding marine natural product aaptamine. Chem Biol Drug Des (2008) 0.84
In vitro and in vivo evaluation of select kahalalide F analogs with antitumor and antifungal activities. Bioorg Med Chem (2011) 0.84
Kahalalides V-Y isolated from a Hawaiian collection of the sacoglossan mollusk Elysia rufescens. J Nat Prod (2008) 0.84
Metabonomics study of urine from Sprague-Dawley rats exposed to Huang-yao-zi using (1)H NMR spectroscopy. J Pharm Biomed Anal (2009) 0.83
Asteropsin A: an unusual cystine-crosslinked peptide from porifera enhances neuronal Ca2+ influx. Biochim Biophys Acta (2013) 0.83
Crystallographic and NMR studies of antiinfective tricyclic guanidine alkaloids from the sponge Monanchora unguifera. Bioorg Med Chem (2004) 0.82
Reducing oyster-associated bacteria levels using supercritical fluid CO2 as an agent of warm pasteurization. Int J Food Microbiol (2009) 0.82
Synthetic modification of manzamine A via Grubbs metathesis. Novel structures with enhanced antibacterial and antiprotozoal properties. Org Lett (2007) 0.82
Atkamine: a new pyrroloiminoquinone scaffold from the cold water Aleutian Islands Latrunculia sponge. Org Lett (2013) 0.82
Complex marine natural products as potential epigenetic and production regulators of antibiotics from a marine Pseudomonas aeruginosa. Microb Ecol (2013) 0.82
Antimicrobial metabolites from the Paracel Islands sponge Agelas mauritiana. J Nat Prod (2012) 0.81
The bat flower: a source of microtubule-destabilizing and -stabilizing compounds with synergistic antiproliferative actions. J Nat Prod (2013) 0.81
2-N-Methyl modifications and SAR studies of manzamine A. Bioorg Med Chem (2008) 0.81
The marine sponge-derived polyketide endoperoxide plakortide F acid mediates its antifungal activity by interfering with calcium homeostasis. Antimicrob Agents Chemother (2011) 0.81
Semisynthetic studies on the manzamine alkaloids. J Nat Prod (2008) 0.80
Structure-activity relationship studies of manzamine A: amidation of positions 6 and 8 of the beta-carboline moiety. Bioorg Med Chem (2009) 0.80
Semisynthetic latrunculin B analogs: studies of actin docking support a proposed mechanism for latrunculin bioactivity. Bioorg Med Chem (2009) 0.80
Vacuum assisted closure of laparostomy wounds "a novel technique". J Ayub Med Coll Abbottabad (2008) 0.80
Chlorolissoclimides: new inhibitors of eukaryotic protein synthesis. RNA (2006) 0.80
Zebra mussel antifouling activity of the marine natural product aaptamine and analogs. Mar Biotechnol (NY) (2006) 0.80
Chemical and biological investigation of the fungus Pulveroboletus ravenelii. J Nat Prod (2003) 0.79
Antiproliferative effects of curcuphenol, a sesquiterpene phenol. Fitoterapia (2010) 0.79
Liver X receptor and peroxisome proliferator-activated receptor agonist from Cornus alternifolia. Biochim Biophys Acta (2012) 0.79
SPK-843 (Aparts/Kaken). Curr Opin Investig Drugs (2005) 0.78
Incomplete modeling of the thromboembolectomy technique. Stroke (2008) 0.78
A New Antimalarial Polyether from a Marine Streptomyces sp. H668. Tetrahedron Lett (2008) 0.78
Araguspongines K and L, new bioactive bis-1-oxaquinolizidine N-oxide alkaloids from Red Sea specimens of Xestospongia exigua. J Nat Prod (2002) 0.78
Natural product studies of U.S. endangered plants: volatile components of Lindera melissifolia (Lauraceae) repel mosquitoes and ticks. Phytochemistry (2012) 0.78
Antiepileptic ceramides from the Red Sea sponge Negombata corticata. J Nat Prod (2008) 0.78
Solution structure of a sponge-derived cystine knot peptide and its notable stability. J Nat Prod (2014) 0.77
Development of antibiotics and the future of marine microorganisms to stem the tide of antibiotic resistance. Curr Opin Investig Drugs (2004) 0.77
Semisynthetic and biotransformation studies of (1S,2E,4S,6R,7E,11E)-2,7,11-cembratriene-4,6-diol. J Nat Prod (2008) 0.77
Design, synthesis, and biological evaluation of Plasmodium falciparum lactate dehydrogenase inhibitors. J Med Chem (2007) 0.77